Projected reductions in HPV-related cancer incidence, by gender.

a<p>Age-standardised incidence rates are expressed as 100,000 per individual and have not been adjusted for world population; rates under no vaccination scenario refer to current rates reported from the Cancer Registry of Norway <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089974#pone.0089974-Cancer1" target="_blank">[21]</a></p>b<p>Projections reflect the expected cancer reduction estimated from the dynamic transmission model for the last cohort to be vaccinated in this analysis. See <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0089974#s2" target="_blank">Methods</a> section for assumptions regarding vaccine efficacy against non-cervical cancers.</p>c<p>Projected reduction in risk of cervical cancer is estimated from the stochastic disease model and in the context of current cervical cancer screening compliance.</p>